Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -18.52% | -42.45% | -36.22% | -33.27% | -25.71% |
| Total Receivables | -6.66% | 67.54% | 280.56% | 24.25% | -15.22% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 58.55% | 44.41% | -34.24% | 269.97% | 388.82% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -14.05% | -31.08% | -26.79% | -28.30% | -22.29% |
|
|
|||||
| Total Current Assets | -14.05% | -31.08% | -26.79% | -28.30% | -22.29% |
| Net Property, Plant & Equipment | -20.95% | 147.17% | 504.97% | 210.50% | 212.69% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -68.11% | -68.09% | -68.32% | 19,521.51% | 18,502.20% |
| Total Assets | -25.57% | -37.60% | -33.52% | -22.45% | -21.73% |
|
|
|||||
| Total Accounts Payable | -23.36% | -36.88% | 155.13% | -63.43% | 5.17% |
| Total Accrued Expenses | 18.03% | 81.22% | 0.18% | 37.70% | 30.34% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 20.31% | 148.88% | 602.99% | 366.77% | 240.38% |
| Total Finance Division Other Current Liabilities | -94.20% | -97.03% | -95.71% | -97.71% | 1,037.10% |
| Total Other Current Liabilities | -94.20% | -97.03% | -95.71% | -97.71% | 1,037.10% |
| Total Current Liabilities | -25.60% | -46.95% | -39.56% | -26.85% | 92.39% |
|
|
|||||
| Total Current Liabilities | -25.60% | -46.95% | -39.56% | -26.85% | 92.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -44.06% | 123.31% | 502.96% | 533.16% | 614.18% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -30.84% | -13.28% | -8.34% | -5.87% | 5.46% |
| Total Liabilities | -29.52% | -29.33% | -24.22% | -12.11% | 27.30% |
|
|
|||||
| Common Stock & APIC | 3.37% | 0.72% | 0.69% | 0.64% | 0.60% |
| Retained Earnings | -7.44% | -7.60% | -7.56% | -6.14% | -8.83% |
| Treasury Stock & Other | -4.07% | 23.01% | 12.79% | -224.07% | -0.04% |
| Total Common Equity | -23.82% | -41.21% | -37.40% | -25.37% | -33.15% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -23.82% | -41.21% | -37.40% | -25.37% | -33.15% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -23.82% | -41.21% | -37.40% | -25.37% | -33.15% |
|
|
|||||